Table 2.

Baseline information and symptoms change of the diabetic gastroparesis patients

Variable		Groups		p-value
		PAK	Placebo
Age (years); Mean ± SD		53.29±11.71	49.08±9.95	0.187a
Duration of diabetes (years); Mean ± SD		10.45±5.19	10.54±6.74	0.962a
Gastroparesis duration (months); Mean ± SD		30.96±30.82	41.71±45.48	0.343a
Sex, n (%)	Male	4 (16.7)	4 (16.7)	1.000b
	Female	20 (83.3)	20 (83.3)
Type of diabetes, n (%)	Type 1	3 (12.5)	4 (16.7)	0.683b
	Type 2	21 (87.5)	20 (83.3)

^aIndependent-samples t-test,

^bChi-Square test